Pathogenesis and pathophysiology of anemia in HIV infection

Annals of Hematology

Volumn 75, Issue 5-6, 1997, Pages 179-187

  Kreuzer, K A ^a,b   Rockstroh, J K ^a  

^a UNIVERSITY OF BONN   (Germany)

^b NONE   (Germany)

Author keywords

Anemia; HIV; Pathogenesis; Pathophysiology

Indexed keywords

CYTOKINE; ERYTHROPOIETIN; GROWTH FACTOR; ZIDOVUDINE;

ANEMIA; BONE MARROW SUPPRESSION; FOLIC ACID DEFICIENCY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IATROGENIC DISEASE; IRON DEFICIENCY; OPPORTUNISTIC INFECTION; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; VITAMIN DEFICIENCY;

ANEMIA; HIV INFECTIONS; HIV-1; HUMANS;

EID: 0030780871     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050340     Document Type: Review

References (100)

1. Abrams DI, Chinn EK, Lewis BJ, Volberding PA, Conant MA, Townsend RM (1984) Hematologic manifestations in homosexual men with Kaposi's sarcoma. Am J Clin Pathol 81:13-18
2. Alvarez-Hernández X, Licéaga J, McKay IC, Brock JH (1989) Induction of hypoferremia and modulation of macrophage iron metabolism by tumor necrosis factor. Lab Invest 61:319-322
3. Baenara GP, Zauli G, Giovannini, Re MC, Furlini G, La Placa M (1990) Early loss of circulating hematopoietic progenitors in HIV-1-infected subjects. Exp Hematol 18:426-430
4. Barosi G (1994) Inadequate erythropoietin response to anemia: definition and clinical relevance. Ann Hematol 68:215-223
5. Barré-Sinoussi F, Cherman JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, Dauget C, Alexer-Blin C, Vezinet-Brun F, Rouzioux C, Rozenbaum W, Montagnier L (1983) Isolation of a T lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220:868-871
6. Baum MK, Shor-Posner G, Lu Y, Rosner B, Sauberlich HE, Fletcher MA, Szapocznik J, Eisdorfer C, Buring JE, Hennekens CH (1995) Micronutrients and HIV-1 disease progression. AIDS 9:1051-1056
7. Baumann MA, Pacheco J, Paul CC, Sorg T, Hillman N (1988) Paroxysmal nocturnal hemoglobinuria associated with the acquired immunodeficiency syndrome. Arch Intern Med 148:212-213
8. Blumberg N, Heal JM (1996) Immunomodulation by blood transfusion: an evolving scientific and clinical challenge. Am J Med 101:299-308
9. Boalaert JR, Weinberg GA, Weinberg ED (1996) Altered iron metabolism in HIV infection: mechanisms, possible consequences, and proposals for management. Infect Agents Dis 5:36-46
10. Broxmeyer HE, Williams DE, Lu L, Cooper S, Anderson SL, Beyer GS, Hoffman R, Rubin BY (1986) The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma. J Immunol 136:4487-4495
11. Burger DM, Meenhorst PL, Koks CHW, Beijnen JH (1993) Drug interactions with zidovudine. AIDS 7:445-460
12. Burkes RL, Cohen H, Krailo M, Sinow RM, Carmel R (1987) Low serum cobalmin levels occur frequently in the acquired immunodeficiency syndrome and related disorders. Eur J Hematol 38:141-147
13. Burstein Y, Rashbaum WK, Hatch WC, Calvelli T, Golodner M, Soeiro R, Lyman WD (1992) Alterations in human fetal hematopoiesis are associated with maternal HIV infection. Pediatr Res 32:155-159
14. Busch MP, Lee T-H, Heitman J (1992) Allogeneic leucocytes but not therapeutic blood elements induce reactivation and dissemination of latent human immunodeficiency virus type 1 infection: implications for transfusion support of infected patients. Blood 80:2128-2135
15. Camacho J, Poveda F, Zamorano AF, Valencia ME, Vazquez JJ, Arnalich F (1992) Serum erythropoietin levels in anaemic patients with advanced human immunodeficiency virus infection. Br J Haematol 82:119-121
16. Canoso RT Zon LI, Groopman JE (1987) Anticardiolipin antibodies associated with HTLV-III infection. Br J Haematol 65:495-498
17. Castaldo A, Tarallo L, Palomba E, Albano F, Russo S, Zuin G, Buffardi F, Guarino A (1996) Iron deficiency and intestinal malabsorption in HIV disease. J Pediatr Gastroenterol Nutr 22:359-363
18. Castella A, Croxson TS, Mildvan D, Witt DH, Zalusky R (1985) The bone marrow in AIDS. Am J Clin Pathol 84:425-432
19. Cheng CL, Smith DE, Carver PL, Cox SR, Watkins PB, Blake DS, Kauffman CA, Meyer KM, Amidon GL, Stetson PL (1996) Steady state pharmacokinetics of delaviridine in HIV positive patients: effect on erythromycin breath test. Clin Pharmacol Ther 61:531-543
20. Chernak E, Dubin G, Henry D, Naides SJ, Hodinka RL, MacGregor RR, Friedmann HM (1995) Infection due to parvovirus B19 in patients infected with human immunodeficiency virus. Clin Infect Dis 20:170-173
21. Chiba M, Hensgleich M, Nishime JA, Balani SK, Lin JH (1996) Role of cytochrome P450 3A4 in human metabolism of MK-639, a potent human immunodeficiency virus protease inhibitor. Drug Metab Dispos 24:307-314
22. Cleveland RP, Liu YC (1996) CD4 expression by erythroid precursor cells in human bone marrow. Blood 87:2275-2282
23. Da Costa NA, Hultin MB (1991) Effective therapy with human immunodeficiency virus-associated anemia with recombinant human erythropoietin despite high endogenous erythropoietin. Am J Hematol 36:71-72
24. Dainiak N, Hardin J, Floyd V, Callahan M, Hoffmann R (1980) Humoral suppression of erythropoiesis in systemic lupus erythemadosus. Am J Med 69:537-544
25. Dainiak N, Worthington M, Riordarn MA, Kreczko S, Goldman L (1988) 3′-azido-3′-deoxythymidine (AZT) inhibits proliferation in vitro of human haematopoietic progenitor cells. Br J Haematol 69:299-304
26. De Angelis V, Biasinutto C, Pradella P, Errante D (1995) Mixed-type autoimmune haemolytic anaemia in a patient with HIV infection. Vox Sang 68:191-194
27. De Miranda P, Good SS, Yarchoan R, Thomas RV, Blum MR, Myers CE, Broder S (1989) Alteration of zidovudine pharmacokinetics by probenecid in patients with AIDS or AIDS-related complex. Clin Pharmacol Ther 46:494-500
28. Donahue RE, Johnson MM, Zon LI, Clark SC, Groopman JE (1987) In vitro suppression of hematopoiesis after human immunodeficiency virus infection. Nature 326:300-302
29. Ellaurie M, Rubinstein A (1995) Elevated tumor necrosis factor-alpha in association with severe anemia in human immunodeficiency infection and mycobacterium avium intracellulare infection. Pediatr Hematol Oncol 12:221-230
30. Falguera M, Perez-Mur J, Puig T, Cao G (1995) Study of the role of vitamin B12 and folinic acid supplementation in preventing toxicity of zidovudine. Eur J Haematol 55:97-102
31. Farina C, Gavazzeni G, Caprioli A, Remuzzi G (1990) Hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infection in acquired immunodeficiency syndrome. Blood 75:2465-2465
32. Fischl MA, Galpin JE, Levine JD, Groopman JE, Henry DH, Kennedy P, Miles S, Robbins W, Starrett B, Zalusky R, Abels RI, Tsai HC, Rudnick SA (1990) Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med 322:1488-1493
33. Folks TM, Kessler SW, Orenstein JM, Justement JS, Jaffe ES, Fauci AS (1988) Infection and replication of HIV-1 in purified progenitor cells of normal human bone marrow. Science 242:919-922
34. Forsyth BW, Andiman WA, O'Connor T (1996) Development of a prognosis-based clinical staging system for infants infected with human immunodeficiency virus. J Pediatr 129:648-655
35. Frontiera N, Meyers A (1987) Peripheral blood and bone marrow abnormalities in te acquired immunodeficiency syndrome. West J Med 147:157-160
36. Fuchs D, Hausen A, Reibnegger G, Werner ER, Werner-Felmayer G, Dierich MP, Wachter H (1991) Immune activation and the anaemia associated with chronic inflammatory disorders. Eur J Haematol 46:65-70
37. Fuller A, Moaven L, Spelman D, Spicer WJ, Wraight H, Curtis D, Leydon J, Doultree J, Locarnini S (1996) Parvovirus B19 in HIV infection: a treatable cause of anemia. Pathology 28:277-280
38. Furlini G, Vignoli M, Ramazotti E, Re MC, Visani G, La Placa (1996) A concurrent human herpesvirus-6 infection renders two human hematopoietic progenitor (TF-1 and KG-1) cell lines susceptible to human immunodeficiency virus type-1. Blood 87:4737-4735
39. Gallicchio VS, Scott KW, Hughes NK, Tse KF, Gaines H, Kirk PR, Birch NJ (1995) Increased hematopoietic toxicity following administration of interferon-α with combination dideoxynucleoside therapy (zidovudine plus ddl) administered in normal mice. Life Sci 56:71-81
40. Garcia-Die F, Remacha A, Cadafalch J, Barceló MJ, Parellada MM, Arza B (1996) The deoxyuridine suppression test in HIV-1 positive patients: the role of azidothymidine (AZT). Eur J Haematol 56:208-212
41. Gardener TD, Flanagan P, Dryden MS, Costello C, Shanson DC, Gazzard BG (1988) Disseminated mycobacterium avium-intracellulare (MAI) infection and red cell hypoplasia in patients with the acquired immune deficiency syndrome (AIDS). J Infect 16:135-140
42. Geissler RG, Rossol R, Mentzel U, Ottmann OG, Klein AS, Gute P, Helm EB, Hoelzer D, Ganser A (1996) Gamma-delta T cell receptor positive lymphocytes inhibit human hematopoietic progenitor cell growth in HIV type 1 infected patients. AIDS Res Hum Retroviruses 12:577-584
43. Gill PS, Rarick M, Brynes RK, Causey D, Loureiro C, Levine AM (1987) Azidothymidine associated with bone marrow failure in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 107:502-505
44. Gogu SR, Malter JS, Agarwal KC (1992) Zidovudine-induced blockade of the expression and function of the erythropoietin receptor. Biochem Pharmacol 44:1009-1012
45. Gupta S, Imam A, Licorish K (1986) Serum ferritin in acquired immune deficiency syndrome. J Clin Lab Immunol 20:11-13
46. Hamburger AW (1995) Impaired cytokine production by bone marrow stromal cells of immunodeficient mice. Br J Haematol 90:750-756
47. Harriman GR, Smith PD, Horne MK, Fox CH, Koenig S, Lack EE, Lane HC, Fauci AS (1989) Vitamin B12 malabsorption in patients with acquired immunodeficiency syndrome. Arch Intern Med 149:2039-2041
48. Henry DH, Beall GN, Benson CA, Carey J, Cone LA, Eron LJ, Fiala M, Fischl MA, Gabin SJ, Gottlieb MS, Galpin JE, Groopman JE, Hooton TM, Jemsek JG, Levine RL, Miles SA, Rinehart JJ, Rios A, Robbins WJ, Ruckdechel JC, Smith JA, Spruance SL, Starrett B, Toney J, Zalusky R, Abels RI, Bryant EC, Larholt KM, Sampson AR, Rudnick SA (1992) Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Ann Intern Med 117:739-748
49. Heyman MR, Rasmussen P (1987) Pneumocystis carinii involvement of the bone marrow in acquired immunodeficiency syndrome. Am J Clin Pathol 87:780-783
50. Horton CM, et al (1994) Pharmacokinetics of oral lamivudine administered alone and with oral zidovudine in asymptomatic patients with human immunodeficiency virus infection. Clin Pharmacol Ther 55:198
51. Inada Y, Lange M, McKinley GF, Sonnabend JA, Fonville TW, Kanemitsu T, Tanaka M, Clark WS (1986) Hematologic correlates and the role of erythrocyte CRI (C3b receptor) in the development of AIDS. AIDS Res 2:235-247
52. Jacobson MA, Peiperl L, Volberding PA, Porteous D, Toy PCTY, Feigal D (1990) Red cell transfusion therapy for anemia in patients with AIDS and ARC: incidence, associated factors, and outcome. Transfusion 30:133-137
53. Jatlow P, McCance EF, Rainey PM, Trapnell CB, Friedland G (1996) Methadone increases zidovudine exposure in HIV infected injection drug users (ACTG 262). 3rd Conference on Retroviruses and Opportunistic Infections, Washington, DC, 1996, January 28-February 1
54. Jelkmann W (1986) Renal erythropoietin. Properties and production. Rev Physiol Biochem Pharmacol 104:139-215
55. Kerr B, Lee C, Yuen G, Anderson R, Daniels R, Grettenberger H, Liang BH, Quart B, Sandoval T, Shetty B, Wu E, Zhang K (1996) Overview of in vitro and in vivo drug interaction studies of nelfinavir mesylate, a new HIV-1 protease inhibitor. 4th Conference on Retroviruses and Opportunistic Infections, Washington, DC, 1996, January 28-February 1
56. Kovacs JA, Kovacs AA, Polis M, Wright WC, Gill VJ, Tuazon CU, Gelmann EP, Lane HC, Longfield R, Ountuf G (1985) Cryptococcus in the acquired immunodeficiency syndrome. Ann Intern Med 103:533-538
57. Kreuzer K-A, Dayer J-M, Rockstroh JK, Sauerbruch T, Spengler U (1997) The interleukin-1 system in HIV infection: peripheral concentrations of interleukin-1 beta, interleukin-1 receptor antagonist and soluble interleukin-1 receptor type II. Clin Exp Immunol 109:54-58
58. Kreuzer K-A, Rockstroh JK, Jelkmann W, Theisen A, Spengler U, Sauerbruch T (1997) Inadequate erythropoietin response to anaemia in HIV patients: relation to serum levels of tumour necrosis factor-alpha, interleukin-6 and their soluble receptors. Br J Haematol 96:235-239
59. Kumar GN, Dykstra J, Jayanti V, Denissen JF (1996) Cytochrome P450 mediated metabolism of the HIV-1 protease inhibitor ritonavir (ABT-538) in human liver microsomes. J Pharm Exp Ther 277:423-431
60. Lambl BB, Federman M, Pleskow D, Wanke CA (1996) Malabsorption and wasting in AIDS patients with microsporidia and pathogen-negative diarrhea. AIDS 10:739-744
61. Lee BL, Täuber MG, Sadler B, Goldstein D, Chambers HF (1996) Atovaquone inhibits the glucuronidation and increases the plasma concentrations of zidovudine. Clin Pharmacol Ther 59:14-21
62. Lerza R, Castello G, Mela GS, Arboscello E, Cerruti A, Bogliolo G, Mencoboni M, Ballarino P, Pannacciulli I (1997) In vitro synergistic inhibition of human bone marrow hematopoietic progenitor growth by a 3′-azido-3′-deoxy-thymidine, 2′3′-dideoxycytidine combination. Exp Hematol 25:252-255
63. Little BJ, Spivak JL, Quinn TC, Mann RB (1986) Kaposi's sarcoma with bone marrow involvement: occurrence in a patient with acquired immunodeficiency syndrome. Am J Med Sci 292:44-46
64. Mandell W, Goldberg DM, Neu HC (1986) Histoplasmosis in patients with the acquired immunodeficiency syndrome. Am J Med 81:974-978
65. Maury CPJ, Andersson LC, Teppo A-M, Partanen S, Juvonen E (1988) Mechanism of anaemia in rheumatoid arthritis: demonstration of raised interleukin-1 beta levels in anaemic patients and of interleukin 1-mediated suppression of normal erythropoisis and of the proliferation of HEL cells in vitro. Ann Rheum Dis 47:972-978
66. McGinniss MH, Macher AM, Rook AH, Alter AJ (1986) Red cell autoantibodies in patients with acquired immune deficiency syndrome. Transfusion 26:405-409
67. Means RT jr, Krantz SB (1992) Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 80:1639-1647
68. Miles SA, Mitsuyasu RT, Moreno J, Baldwin G, Alton NK, Souza L, Glaspy JA (1991) Combined therapy with recombinant granulocyte-colony stimulating factor and erythropoietin decreases hematologic toxicity from zidovudine. Blood 77:2109-2117
69. Mir N, Costello C, Luckit J, Lindley R (1989) HIV disease and bone marrow changes: a study of 60 cases. Eur J Haematol 42:339-343
70. Molinea JM, Scadden DT, Sakaguchi M, et al (1990) Lack of evidence for infection of or effect on growth of hematopoietic progenitor cells after in vivo or in vitro exposure to human immunodeficiency virus. Blood 12:2476
71. Moses AV, Williams S, Heneveld, Strussenberg J, Rarick M, Loveless M, Bagby G, Nelson JA (1996) Human immunodeficiency virus infection of bone marrow endothelium reduces induction of stromal hematopoietic growth factors. Blood 87:919-925
72. Mudido PM, Georgers D, Dorazio D, Yen-Liebrman B, Bae S, O'Brien WA, Spritzler J, Lederman MM (1996) Human immunodeficiency virus type 1 activation after blood transfusion. Transfusion 36:860-865
73. Paltiel O, Falutz J, Veilleux M, Rosenblatt DS, Gordon K (1995) Clinical correlates of subnormal vitamin B12 levels in patients infected with the human immunodeficiency virus. Am J Hematol 49:318-322
74. Perkocha LA, Rodgers GM (1988) Hematologic aspects of human immunodeficiency virus infection: laboratory and clinical considerations. Am J Hematol 29:94-105
75. Piscitelli SC, Flexner C, Minor JR, Polis MA, Masur H (1996) Drug interactions in patients infected with human immunodeficiency virus. Clin Infect Dis 23:685-693
76. Rameshwar P, Denny TN, Gascón P (1996) Enhanced HIV-1 activity in bone marrow can lead to myelopoietic suppression partially contributed by gag p24. J Immunol 157:4244-4250
77. Reid CDL, Prouse PJ, Baptista LC, Gumpel JM, Chanarin I (1984) The mechanism of the anaemia in rheumatoid arthritis: effects of bone marrow adherent cells and of serum on invitro erythropoisis. Br J Haematol 58:607-615
78. Richman DD, Fischl MA, Grieco MH and the AZT Collaborative Working Group (1987) The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. N Engl J Med 317:192-197
79. Rogers J, Durmowicz G, Kasschau K, Lacroix L, Bridges K (1991) A motif within the 5′ non-coding regions of acute phase mRNAs mediates ferritin translation by IL-1β and may contribute to the anemia of chronic disease (abstract). Blood [Suppl 1] 367a
80. Roy S, Wainberg MA (1988) Role of the mononuclear phagocyte system in the development of acquired immunodeficiency (AIDS). J Leuk Biol 43:91-97
81. Sahai J, Gallicano K, Pakuts A, Cameron DW (1994) Effect of fluconazole on zidovudine pharmacokinetics in patients infected with human immunodeficiency virus. J Infect Dis 169:1103-1107
82. Scadden DT, Zaira M, Woon A, Wang Z, Schieve L, Ikeuchi K, Lim B, Groopman JE (1989) Human immunodeficiency virus infection of human bone marrow stromal fibroblasts. Blood 74:317-322
83. Schneider DR, Picker LJ (1985) Myelodysplasia in the acquired immune deficiency syndrome. Am J Clin Pathol 84:144-152
84. Sim SM, Back DJ, Breckenridge AM (1991) The effect of various drugs on the glucuronidation of zidovudine (azidothymidine; AZT) by human liver microsomes. Br J Clin Pharmacol 32:17-21
85. Spivak JL, Barnes DC, Fuchs E, Quinn TC (1989) Serum immunoreactive erythropoietin in HIV infected patients. JAMA 261:3104-3107
86. Spivak JL, Bender BS, Quinn TC (1984) Hematologic abnormalities in the acquired immune deficiency syndrome. Am J Med 77:224-228
87. Sun CH, Ward HJ, Paul WL, Koyle MA, Yanagawa N, Lee DBN (1989) Serum erythropoietin levels after renal transplantation. N Engl J Med 321:151-157
88. Tang AM, Graham NM, Chandra RK, Saah AJ (1997) Low serum vitamin B12 concentrations are associated with faster human immunodeficiency virus type 1 (HIV-1) disease progression. J Nutr 127:345-351
89. Taniguchi S, Dai CH, Krantz SB (1997) Specific binding of interferon-gamma to high affinity receptors on human erythroid colony-forming cells. Exp Hematol 25:193-198
90. Telen MJ, Roberts KB, Bartlett JA (1990) HIV associated autoimmune hemolytic anemia: a report of a case and review of the literature. J Acquir Immune Defic Syndr Hum Retroviral 3:933-937
91. Toy PTCY, Reid ME, Burns M (1985) Positive direct anti-globulin test associated with hyperglobulinemia in acquired immunodeficiency syndrome (AIDS). Am J Hematol 19:145-150
92. Treacy M, Lai L, Castello C, Clark A (1987) Peripheral blood and bone marrow abnormalities in patients with HIV related disease. Br J Haematol 65:289-294
93. Vamvakas E, Kaplan HS (1993) Early transfusion and length of survival in acquired immune deficiency syndrome: experience with a population receiving medical care at a public hospital. Transfusion 33:111-118
94. Van der Lelie J, Lange JM, Vos JJ, Dalen CM van, Danner SA, Borne AEG von dem (1987) Autoimmunity against blood cells in the human immunodeficiency virus (HIV) infection. Br J Haematol 67:109-114
95. Van Elsacker-Neile AM, Kroon FP, van der Ende ME, Salimans MM, Spaan WJ, Kroes AC (1996) Prevalence of parvovirus B19 infection in patients infected with human immunodeficiency virus. Clin Infect Dis 23:1255-1260
96. Walker RE, Parker RI, Kovacs JA, et al (1988) Anemia and erythropoiesis in patients with the acquired immunodeficiency syndrome (AIDS) and Kaposi sarcoma treated with zidovudine. Ann Int Med 108:372-376
97. Wang Z, Goldberg MA, Scadden DT (1993) HIV-1 suppresses erythropoietin production in vitro. Exp Hematol 21:683-688
98. Ward JW, Bush TJ, Perkins HA, Lieb LE, Allen JR, Goldfinger D, Samson SM, Pepkowitz SH, Fernando LP, Holland PV (1989) The natural history of transfusion-associated infection with human immunodeficiency virus. N Engl J Med 321:947-952
99. Zanjani ED, McGlave PB, Davis SF, Bonisadre M, Kaplan ME, Sarosi GA (1982) In vitro suppression of erythropoiesis by bone marrow adherent cells from some patients with fungal infection. Br J Haematol 50:419
100. Zon LI, Arkin C, Groopman JE (1987) Haematologic manifestations of the human immunodeficiency virus (HIV). Br J Haematol 66:251-256